Trials / Active Not Recruiting
Active Not RecruitingNCT05692596
The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 317 (estimated)
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The long-term goal of our PIC is to develop effective strategies that can be applied clinically at the point-of-care to prevent, intercept, or detect PDAC at an early stage, thereby reducing PDAC burden and saving lives.
Conditions
- Pancreatic Ductal Adenocarcinoma
- Pancreatic Cyst
- Chronic Pancreatitis
- Fatty Pancreas
- Genetic Pancreatic Cancer
- Genetic Pancreatitis
- BRCA Mutation
- Lynch Syndrome
- FAP
- Familial Atypical Multiple Mole-Melanoma
- PALB2 Gene Mutation
- Peutz-Jeghers Syndrome
- Ataxia Telangiectasia
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Data collection | Investigators will compile data typically collected clinically. This data will include demographics, cancer screening procedures, cancer diagnosis and staging, chemotherapy, immunotherapy, radiation therapy, surgery, comorbidities, medication use, lifestyle and other cancer risk factors, quality of life, vital status, and molecular data generated from specimens collected clinically. |
Timeline
- Start date
- 2022-10-06
- Primary completion
- 2026-07-01
- Completion
- 2026-07-01
- First posted
- 2023-01-20
- Last updated
- 2026-04-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05692596. Inclusion in this directory is not an endorsement.